Harbin Medisan Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 36.60% vs -19.51% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 93.43% vs -81.71% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "228.80",
          "val2": "167.50",
          "chgp": "36.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-19.40",
          "val2": "-127.50",
          "chgp": "84.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.40",
          "val2": "6.00",
          "chgp": "23.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.00",
          "val2": "2.00",
          "chgp": "-350.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.70",
          "val2": "-117.20",
          "chgp": "93.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-85.00%",
          "val2": "-761.30%",
          "chgp": "67.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.92% vs 15.67% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -21.54% vs 164.53% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,120.60",
          "val2": "1,178.60",
          "chgp": "-4.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "149.20",
          "val2": "105.90",
          "chgp": "40.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.30",
          "val2": "24.10",
          "chgp": "13.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.50",
          "val2": "16.00",
          "chgp": "-190.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "55.00",
          "val2": "70.10",
          "chgp": "-21.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.10%",
          "val2": "-6.90%",
          "chgp": "3.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Sep'25

Change(%)

Net Sales

228.80

167.50

36.60%

Operating Profit (PBDIT) excl Other Income

-19.40

-127.50

84.78%

Interest

7.40

6.00

23.33%

Exceptional Items

-5.00

2.00

-350.00%

Consolidate Net Profit

-7.70

-117.20

93.43%

Operating Profit Margin (Excl OI)

-85.00%

-761.30%

67.63%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 36.60% vs -19.51% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 93.43% vs -81.71% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,120.60

1,178.60

-4.92%

Operating Profit (PBDIT) excl Other Income

149.20

105.90

40.89%

Interest

27.30

24.10

13.28%

Exceptional Items

-14.50

16.00

-190.62%

Consolidate Net Profit

55.00

70.10

-21.54%

Operating Profit Margin (Excl OI)

29.10%

-6.90%

3.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -4.92% vs 15.67% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -21.54% vs 164.53% in Dec 2023

All Annual Results